Daily Market Reports | Nov 20 2025
This story features AUSSIE BROADBAND LIMITED, and other companies.
For more info SHARE ANALYSIS: ABB
The company is included in ASX200, ASX300 and ALL-ORDS
An additional news report on the recommendation, valuation, forecast and opinion changes and updates for ASX-listed equities.
In addition to The Australian Broker Call Report, which is published and updated daily (Mon-Fri), FNArena has now added The Australian Broker Call *Extra* Edition, featuring additional sources of research and insights on ASX-listed stocks, also enlarging the number of stocks that make up the FNArena universe.
One key difference is the *Extra* Edition will not be updated daily, but merely “regularly” depending on availability of suitable quality content. As such, the *Extra* Edition tries to build a bridge between daily updates via the Australian Broker Call Report and ad hoc news stories, that are not always timely for investors hungry for the next information update.
Investors using the *Extra* Edition as a source of input for their own share market research should thus take into account that information after publication may not be up to date, or yet awaiting another update by FNArena’s team of journalists.
Similar to The Australian Broker Call Report, this *Extra* Edition includes concise but limited reviews of research recently published by Stockbrokers and other experts, which should be considered as information concerning likely market behaviour rather than advice on the securities mentioned. Do not act on the contents of this Report without first reading the important information included at the end of this Report.
The Australian Broker Call *Extra* Edition is a summary that has been prepared independently of the sources identified. Readers will check the full text of the recommendations and consult a Licenced Advisor before making any investment decision.
The copyright of this Report is owned by the publisher. Readers will not copy, forward or disseminate this Report to any other person. For more vital information about the sources included, see the bottom of this Report.
COMPANIES DISCUSSED IN THIS ISSUE
Click on a symbol for fast access.
The number next to the symbol represents the number of brokers covering it for this report -(if more than 1)
ABB ACF ALC CAT CNU COH CXL FFM PME SLC TNE TPG
ABB AUSSIE BROADBAND LIMITED
Telecommunication – Overnight Price: $4.99
Canaccord Genuity rates ((ABB)) as Buy (1) –
Canaccord Genuity points to Telstra Group’s ((TLS)) Black Friday sale including -50% off all speeds for three months whereas last year’s was the same promotion but for two months.
Comparing between Telstra at $99/mth ex modem and $113/mth with modem with Superloop ((SLC)) at $95/mth including a modem subject to a 24-month connection and Aussie Broadband also $95/mth, the analyst believes “value” rarely chose Telstra, so the price change may have a limited impact on the competitive backdrop.
The share price pullbacks offer a good opportunity for both Superloop and Aussie Broadband, the broker suggests.
The broker retains a Buy rating and $6.85c target price for Aussie Broadband.
This report was published on November 18, 2025.
Target price is $6.85 Current Price is $4.99 Difference: $1.86
If ABB meets the Canaccord Genuity target it will return approximately 37% (excluding dividends, fees and charges).
Current consensus price target is $6.01, suggesting upside of 20.4%(ex-dividends)
The company’s fiscal year ends in June.
Forecast for FY26:
Canaccord Genuity forecasts a full year FY26 dividend of 6.30 cents and EPS of 18.10 cents.
At the last closing share price the estimated dividend yield is 1.26%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 27.57.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 19.6, implying annual growth of 75.2%.
Current consensus DPS estimate is 6.4, implying a prospective dividend yield of 1.3%.
Current consensus EPS estimate suggests the PER is 25.5.
Forecast for FY27:
Canaccord Genuity forecasts a full year FY27 dividend of 10.60 cents and EPS of 26.50 cents.
At the last closing share price the estimated dividend yield is 2.12%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 18.83.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 25.9, implying annual growth of 32.1%.
Current consensus DPS estimate is 8.1, implying a prospective dividend yield of 1.6%.
Current consensus EPS estimate suggests the PER is 19.3.
Market Sentiment: 0.8
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
ACF ACROW LIMITED
Building Products & Services – Overnight Price: $1.04
Moelis rates ((ACF)) as Buy (1) –
Management at Acrow delivered a trading update at its AGM, with Moelis noting 1H26 revenue guidance of $153-157m and earnings (EBITDA) of $37-40m, reflecting moves of 22% and -1%, respectively, year-on-year at midpoints.
The analysts highlight continued softness in Formwork, particularly in Queensland, though operations in SA and WA remain supportive.
Management expects a Queensland recovery into 4Q26 with Olympics-related demand from 1H27.
Industrial Access remains the key strength, in the broker’s view, with FY26 revenue expected to approach $200m, representing a larger share of group revenue.
Moelis retains a Buy rating with a target of $1.31, down from $1.32.
This report was published on November 18, 2025.
Target price is $1.31 Current Price is $1.04 Difference: $0.265
If ACF meets the Moelis target it will return approximately 25% (excluding dividends, fees and charges).
Current consensus price target is $1.26, suggesting upside of 20.9%(ex-dividends)
The company’s fiscal year ends in June.
Forecast for FY26:
Moelis forecasts a full year FY26 dividend of 5.10 cents and EPS of 10.20 cents.
At the last closing share price the estimated dividend yield is 4.88%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 10.25.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 10.3, implying annual growth of 36.1%.
Current consensus DPS estimate is 5.6, implying a prospective dividend yield of 5.4%.
Current consensus EPS estimate suggests the PER is 10.1.
Forecast for FY27:
Moelis forecasts a full year FY27 dividend of 6.10 cents and EPS of 12.20 cents.
At the last closing share price the estimated dividend yield is 5.84%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 8.57.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 12.4, implying annual growth of 20.4%.
Current consensus DPS estimate is 6.3, implying a prospective dividend yield of 6.0%.
Current consensus EPS estimate suggests the PER is 8.4.
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
ALC ALCIDION GROUP LIMITED
Healthcare services – Overnight Price: $0.11
Canaccord Genuity rates ((ALC)) as Buy (1) –
Alcidion Group has expanded the contract with Leidos, which is a global technology firm specialising in defence.
Canaccord Genuity notes this is a positive development, given its contribution to FY26 revenue, and validates the company’s “land and expand” strategy.
It suggests Alcidon can meet guidance and the broker’s forecasts. Buy rating and $0.13 target maintained.
This report was published on November 17, 2025.
Target price is $0.13 Current Price is $0.11 Difference: $0.02
If ALC meets the Canaccord Genuity target it will return approximately 18% (excluding dividends, fees and charges).
The company’s fiscal year ends in June.
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
CAT CATAPULT SPORTS LIMITED
Medical Equipment & Devices – Overnight Price: $4.46
Canaccord Genuity rates ((CAT)) as Buy (1) –
Catapult Sports announced 1H26 numbers that were a slight ‘beat’ on largely pre-reported results.
Canaccord Genuity notes revenue rose 16% y/y in constant currency, with subscription revenue growth of 20% y/y which aligns with its 20% growth in annual contract value. Gross profit lifted 17% y/y with a 79% gross margin.
Management retained the positive outlook for FY26, flagging “strong annual contract growth and low churn”.
The analyst highlights the rotation out of growth stocks over the last month and views the sell down in the share price at over -35% as overdone.
Buy rating retained with an unchanged target of $8.
This report was published on November 18, 2025.
Target price is $8.00 Current Price is $4.46 Difference: $3.54
If CAT meets the Canaccord Genuity target it will return approximately 79% (excluding dividends, fees and charges).
Current consensus price target is $7.17, suggesting upside of 60.7%(ex-dividends)
The company’s fiscal year ends in March.
Forecast for FY26:
Canaccord Genuity forecasts a full year FY26 dividend of 0.00 cents and EPS of minus 0.47 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is minus 955.03.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is -5.3, implying annual growth of N/A.
Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.
Current consensus EPS estimate suggests the PER is N/A.
Forecast for FY27:
Canaccord Genuity forecasts a full year FY27 dividend of 0.00 cents and EPS of 4.05 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 110.15.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is -0.3, implying annual growth of N/A.
Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.
Current consensus EPS estimate suggests the PER is N/A.
This company reports in USD. All estimates have been converted into AUD by FNArena at present FX values.
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
CNU CHORUS LIMITED
Telecommunication – Overnight Price: $7.95
Jarden rates ((CNU)) as Underweight (4) –
Jarden notes Standard and Poor’s has applied its new digital infrastructure rating to Chorus, resulting in a major increase in the “down driver” for its BBB rating, signalling a potential upgrade to BBB-plus, with the outlook raised to positive.
Debt/EBITDA is calculated around 4.5x, highlighting significant headroom. Jarden does not expect any meaningful change in approach to capital management, noting the company’s clear dividend policy and the “Moody’s constraint”, with the latter’s calculations slightly different to S&P and signalling less headroom.
The broker expects low single-digit growth in the dividend to be maintained with debt capacity likely to remain underutilised. Underweight retained. Target rises to NZ$8.50 from NZ$8.37.
This report was published on November 17, 2025.
Current Price is $7.95. Target price not assessed.
The company’s fiscal year ends in June.
Forecast for FY26:
Jarden forecasts a full year FY26 dividend of 54.38 cents and EPS of 13.69 cents.
At the last closing share price the estimated dividend yield is 6.84%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 58.09.
Forecast for FY27:
Jarden forecasts a full year FY27 dividend of 55.29 cents and EPS of 15.77 cents.
At the last closing share price the estimated dividend yield is 6.95%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 50.41.
This company reports in NZD. All estimates have been converted into AUD by FNArena at present FX values.
Market Sentiment: 0.5
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
COH COCHLEAR LIMITED
Medical Equipment & Devices – Overnight Price: $269.80
Canaccord Genuity rates ((COH)) as Buy (1) –
Canaccord Genuity points out the Sonova first half result has put the spotlight on the first/second half skew in Cochlear’s FY26 guidance.
While recognising the degree of skew may limit the performance of the stock in the short term, the broker envisages an opportunity to accumulate below $285 a share.
Canaccord Genuity believes the stock can outperform from the second half onwards as the Nexa cochlear implant system is launched. Buy rating and $330 target.
This report was published on November 17, 2025.
Target price is $330.00 Current Price is $269.80 Difference: $60.2
If COH meets the Canaccord Genuity target it will return approximately 22% (excluding dividends, fees and charges).
Current consensus price target is $306.74, suggesting upside of 13.7%(ex-dividends)
The company’s fiscal year ends in June.
Forecast for FY26:
Canaccord Genuity forecasts a full year FY26 dividend of 460.00 cents and EPS of 664.80 cents.
At the last closing share price the estimated dividend yield is 1.70%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 40.58.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 690.3, implying annual growth of 16.2%.
Current consensus DPS estimate is 493.8, implying a prospective dividend yield of 1.8%.
Current consensus EPS estimate suggests the PER is 39.1.
Forecast for FY27:
Canaccord Genuity forecasts a full year FY27 dividend of 510.00 cents and EPS of 739.80 cents.
At the last closing share price the estimated dividend yield is 1.89%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 36.47.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 785.0, implying annual growth of 13.7%.
Current consensus DPS estimate is 561.6, implying a prospective dividend yield of 2.1%.
Current consensus EPS estimate suggests the PER is 34.4.
Market Sentiment: -0.2
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
CXL CALIX LIMITED
Industrial Sector Contractors & Engineers – Overnight Price: $0.57
Canaccord Genuity rates ((CXL)) as Buy (1) –
Calix has a joint development agreement with Rio Tinto ((RIO)) which Canaccord Genuity believes is a significant step forward for its zero emissions steel technology. A demonstration plant site in Western Australia has been selected.
Rio Tinto will contribute around $35m in value to the project with a further $27m of “in-kind” value. The latter will assist with the successful development, commissioning and marketing of product.
The broker lauds the heft of Rio Tinto as a potential step in raising external funding for the plan. Buy rating and $1.95 target.
This report was published on November 17, 2025.
Target price is $1.95 Current Price is $0.57 Difference: $1.38
If CXL meets the Canaccord Genuity target it will return approximately 242% (excluding dividends, fees and charges).
The company’s fiscal year ends in June.
Forecast for FY26:
Canaccord Genuity forecasts a full year FY26 EPS of minus 10.60 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is minus 5.38.
Forecast for FY27:
Canaccord Genuity forecasts a full year FY27 EPS of minus 2.20 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is minus 25.91.
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
FFM FIREFLY METALS LIMITED
Gold & Silver – Overnight Price: $1.74
Moelis rates ((FFM)) as Buy (1) –
FireFly Metals’ updated Mineral Resource for Green Bay is described by Moelis as a major uplift, with 79.7mt at 1.8% copper supporting 1.4mt contained copper and 1.1moz of gold.
The broker views the around 400kt copper addition, doubling of gold and stronger Measured and Indicated categories as enhancing geological confidence and supporting future reserve conversion.
It’s felt elevated drilling activity, backed by $114m cash, should maintain strong momentum ahead of restart studies in 2026.
Moelis sees Green Bay as a scarce, high-quality asset likely to attract corporate interest despite permitting and financing risks. Buy rating and target of $2.20.
This report was published on November 18, 2025.
Target price is $2.20 Current Price is $1.74 Difference: $0.465
If FFM meets the Moelis target it will return approximately 27% (excluding dividends, fees and charges).
Current consensus price target is $1.87, suggesting upside of 7.6%(ex-dividends)
Forecast for FY26:
Current consensus EPS estimate is -3.1, implying annual growth of N/A.
Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.
Current consensus EPS estimate suggests the PER is N/A.
Forecast for FY27:
Current consensus EPS estimate is -2.3, implying annual growth of N/A.
Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.
Current consensus EPS estimate suggests the PER is N/A.
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
PME PRO MEDICUS LIMITED
Medical Equipment & Devices – Overnight Price: $250.37
Canaccord Genuity rates ((PME)) as Buy (1) –
Canaccord Genuity maintains its Buy rating and $350 target price on Pro Medicus, highlighting the valuation of the stock as over 100x EV/EBITDA naturally brings forth periods of volatility. The recent de-rating offers an opportunity for accumulation of the stock.
Part of the de-rating, the analyst proposes, comes from the “dire” outlook for rural and regional hospitals resulting from the One Big Beautiful Bill and cuts to US healthcare funding via Medicaid.
The broker is continuing to research this narrative but states the growth in decentralisation of radiology that has been in place for years in the US will continue.
The medtech announced a new five-year contract for a minimum of $44m with Advanced Radiology Management (ARM) and brings 1H26 new contract wins to $234m.
Canaccord Genuity notes the ARM win proves there is a market for product/services at the premium end (Pro Medicus) and not necessarily the lower quality and cheaper end of the market. The growth of reading groups (ARM) or teleradiology has both investment and growth.
This report was published on November 18, 2025.
Target price is $350.00 Current Price is $250.37 Difference: $99.63
If PME meets the Canaccord Genuity target it will return approximately 40% (excluding dividends, fees and charges).
Current consensus price target is $322.77, suggesting upside of 28.9%(ex-dividends)
The company’s fiscal year ends in June.
Forecast for FY26:
Canaccord Genuity forecasts a full year FY26 dividend of 75.00 cents and EPS of 150.30 cents.
At the last closing share price the estimated dividend yield is 0.30%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 166.58.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 152.9, implying annual growth of 38.6%.
Current consensus DPS estimate is 76.6, implying a prospective dividend yield of 0.3%.
Current consensus EPS estimate suggests the PER is 163.7.
Forecast for FY27:
Canaccord Genuity forecasts a full year FY27 dividend of 101.00 cents and EPS of 203.00 cents.
At the last closing share price the estimated dividend yield is 0.40%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 123.33.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 202.8, implying annual growth of 32.6%.
Current consensus DPS estimate is 108.0, implying a prospective dividend yield of 0.4%.
Current consensus EPS estimate suggests the PER is 123.5.
Market Sentiment: 0.6
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
SLC SUPERLOOP LIMITED
Telecommunication – Overnight Price: $2.31
Canaccord Genuity rates ((SLC)) as Buy (1) –
Canaccord Genuity points to Telstra Group’s ((TLS)) Black Friday sale including -50% off all speeds for three months whereas last year’s was the same promotion but for two months.
Comparing between Telstra at $99/mth ex modem and $113/mth with modem with Superloop at $95/mth including a modem subject to a 24-month connection and Aussie Broadband ((ABB)) also $95/mth, the analyst believes “value” rarely chose Telstra, so the price change may have a limited impact on the competitive backdrop.
The broker suggests share price pullbacks offer a good opportunity for both Superloop and Aussie Broadband.
Superloop is rated Buy with a $3.74 target price.
This report was published on November 18, 2025.
Target price is $3.74 Current Price is $2.31 Difference: $1.43
If SLC meets the Canaccord Genuity target it will return approximately 62% (excluding dividends, fees and charges).
Current consensus price target is $3.53, suggesting upside of 52.8%(ex-dividends)
The company’s fiscal year ends in June.
Forecast for FY26:
Canaccord Genuity forecasts a full year FY26 dividend of 0.00 cents and EPS of 0.80 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 288.75.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 6.8, implying annual growth of 2733.3%.
Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.
Current consensus EPS estimate suggests the PER is 34.0.
Forecast for FY27:
Canaccord Genuity forecasts a full year FY27 dividend of 0.00 cents and EPS of 4.70 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 49.15.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 8.3, implying annual growth of 22.1%.
Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.
Current consensus EPS estimate suggests the PER is 27.8.
Market Sentiment: 0.9
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
TNE TECHNOLOGY ONE LIMITED
IT & Support – Overnight Price: $29.27
Canaccord Genuity rates ((TNE)) as Buy (1) –
Dissecting TechnologyOne’s FY25 results, Canaccord Genuity points to the lower than expected annual recurring revenue growth of 18% y/y.
This was -2% below both its own forecast and consensus despite some strong half-on-half robust UK growth and larger sized deals.
Profit before tax rose 19% y/y and met forecasts although there was a marginal drag, the analyst notes, from Courseloop.
Free cashflow was viewed as the highlight, up 61% y/y with improved working capital of around $63m, beats on forecasts and consensus by 32-34%. A special 10c per share dividend was declared.
On the negative side, net revenue retention of 115% in 2H25 was lower than 1H at 118% and 117% in FY24. The book upgrade program and the new “Plus” is estimated to be worth 1ppt of net revenue retention in FY26 and into the medium term.
Canaccord Genuity sees the share price pullback as a good opportunity to “wade in” with a Buy rating and revised target of $42.15 from $45 previously.
This report was published on November 19, 2025.
Target price is $42.15 Current Price is $29.27 Difference: $12.88
If TNE meets the Canaccord Genuity target it will return approximately 44% (excluding dividends, fees and charges).
Current consensus price target is $36.11, suggesting upside of 23.4%(ex-dividends)
The company’s fiscal year ends in September.
Forecast for FY26:
Canaccord Genuity forecasts a full year FY26 dividend of 35.00 cents and EPS of 50.00 cents.
At the last closing share price the estimated dividend yield is 1.20%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 58.54.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 48.9, implying annual growth of N/A.
Current consensus DPS estimate is 31.9, implying a prospective dividend yield of 1.1%.
Current consensus EPS estimate suggests the PER is 59.9.
Forecast for FY27:
Canaccord Genuity forecasts a full year FY27 dividend of 42.00 cents and EPS of 60.00 cents.
At the last closing share price the estimated dividend yield is 1.43%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 48.78.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 57.9, implying annual growth of 18.4%.
Current consensus DPS estimate is 38.9, implying a prospective dividend yield of 1.3%.
Current consensus EPS estimate suggests the PER is 50.6.
Market Sentiment: 0.4
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
TPG TPG TELECOM LIMITED
Telecommunication – Overnight Price: $3.73
Jarden rates ((TPG)) as Overweight (2) –
Jarden now values TPG Telecom ex its capital reduction and special dividend. With a reset balance sheet and simplified model the focus is now on the ability to grow earnings through sustainable top-line momentum.
The sale of the EG&W assets and handset receivables has meant the company has a cleaner balance sheet and improved equity story, the broker adds.
In the short term, industry revenues are solid and this supports earnings momentum and Jarden maintains an Overweight rating.
Target is reduced to $3.70 from $5.25, reflecting the capital return that is offset slightly by a change in share count assumptions associated with the reinvestment plan.
This report was published on November 17, 2025.
Target price is $3.70 Current Price is $3.73 Difference: minus $0.03 (current price is over target).
If TPG meets the Jarden target it will return approximately minus 1% (excluding dividends, fees and charges – negative figures indicate an expected loss).
Current consensus price target is $5.39, suggesting upside of 44.5%(ex-dividends)
The company’s fiscal year ends in December.
Forecast for FY25:
Jarden forecasts a full year FY25 EPS of 8.10 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 46.05.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 16.2, implying annual growth of N/A.
Current consensus DPS estimate is 18.0, implying a prospective dividend yield of 4.8%.
Current consensus EPS estimate suggests the PER is 23.0.
Forecast for FY26:
Jarden forecasts a full year FY26 EPS of 12.50 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 29.84.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 19.6, implying annual growth of 21.0%.
Current consensus DPS estimate is 19.3, implying a prospective dividend yield of 5.2%.
Current consensus EPS estimate suggests the PER is 19.0.
Market Sentiment: 0.1
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
Disclaimer:
The content of this information does in no way reflect the opinions of FNArena, or of its journalists. In fact we don’t have any opinion about the stock market, its value, future direction or individual shares. FNArena solely reports about what the main experts in the market note, believe and comment on. By doing so we believe we provide experienced, intelligent investors with a valuable tool that helps them in making up their own minds, reading market trends and getting a feel for what is happening beneath the surface.
This document is provided for informational purposes only. It does not constitute an offer to sell or a solicitation to buy any security or other financial instrument. FNArena employs very experienced journalists who base their work on information believed to be reliable and accurate, though no guarantee is given that the daily report is accurate or complete. Investors should contact their personal adviser before making any investment decision.
<span style="
Click to view our Glossary of Financial Terms
CHARTS
For more info SHARE ANALYSIS: ABB - AUSSIE BROADBAND LIMITED
For more info SHARE ANALYSIS: ACF - ACROW LIMITED
For more info SHARE ANALYSIS: ALC - ALCIDION GROUP LIMITED
For more info SHARE ANALYSIS: CAT - CATAPULT SPORTS LIMITED
For more info SHARE ANALYSIS: CNU - CHORUS LIMITED
For more info SHARE ANALYSIS: COH - COCHLEAR LIMITED
For more info SHARE ANALYSIS: CXL - CALIX LIMITED
For more info SHARE ANALYSIS: FFM - FIREFLY METALS LIMITED
For more info SHARE ANALYSIS: PME - PRO MEDICUS LIMITED
For more info SHARE ANALYSIS: RIO - RIO TINTO LIMITED
For more info SHARE ANALYSIS: SLC - SUPERLOOP LIMITED
For more info SHARE ANALYSIS: TLS - TELSTRA GROUP LIMITED
For more info SHARE ANALYSIS: TNE - TECHNOLOGY ONE LIMITED
For more info SHARE ANALYSIS: TPG - TPG TELECOM LIMITED